| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |